Controlled Substance Monitoring
System for tracking and monitoring prescriptions of controlled substances to prevent abuse and ensure compliance.
Controlled substance monitoring involves systems and processes for tracking and monitoring prescriptions of controlled substances (such as opioids, benzodiazepines, and stimulants) to prevent abuse, diversion, and ensure regulatory compliance. These systems include prescription drug monitoring programs (PDMPs), real-time monitoring, and reporting requirements. Effective monitoring helps identify patterns of misuse, supports appropriate prescribing, and protects patient safety.
Keywords
Related Terms
HIPAA Compliance
HIPAA (Health Insurance Portability and Accountability Act) sets the standard for protecting sensitive patient health information in the United States.
EPCS
Electronic Prescribing for Controlled Substances (EPCS) is a DEA requirement enabling practitioners to write and transmit prescriptions for Schedule II-V drugs electronically.
DEA Registration
DEA registration is the mandatory federal registration required for healthcare practitioners and facilities to prescribe, dispense, or handle controlled substances.
DR-107
DR-107 is the Israeli Ministry of Health regulation governing digital prescriptions, defining standards for electronic creation, signing, and transmission of prescriptions.
Form 29C
Form 29C is the Israeli institutional drug approval form used by hospitals and healthcare facilities for authorizing the use of specific medications for individual patients.
Opioid Management
Opioid management encompasses the clinical systems, monitoring tools, and regulatory controls used to ensure safe prescribing and dispensing of opioid medications.
Every Medication Workflow. Connected.
Formidable develops the systems that let healthcare organizations prescribe, sign, harmonize, and dispense — digitally and compliantly. From electronic prescriptions to FHIR interoperability, we turn complex workflows into production-ready software.